0
STAAR Act
12/29/2022, 12:48 PM
Summary of Bill HR 9094
The STAAR Act aims to improve the quality of education by implementing a standardized testing system that measures student performance in key subjects such as math, reading, and science. This testing system will be used to assess student progress and hold schools accountable for their performance.
Additionally, the STAAR Act includes provisions for providing additional resources and support to schools that are struggling to meet academic standards. This may include funding for professional development for teachers, intervention programs for struggling students, and other resources to help improve student outcomes. Overall, the STAAR Act is designed to promote academic excellence and ensure that all students have access to a high-quality education. It emphasizes the importance of accountability and transparency in the education system, with the goal of improving student achievement and closing achievement gaps among different student populations.
Congressional Summary of HR 9094
Strategies To Address Antimicrobial Resistance Act or the STAAR Act
This bill expands various initiatives to address antimicrobial resistance.
The bill reestablishes the interagency Antimicrobial Resistance Task Force to coordinate and develop efforts addressing antimicrobial resistance.
The Department of Health and Human Services must encourage health care facilities to implement antimicrobial stewardship programs to evaluate and improve the use of antimicrobial drugs.
The bill also requires the use of the National Healthcare Safety Network and similar surveillance systems to collect and report data about the usage of antimicrobial drugs, changes in resistance to such drugs, and other trends impacting patient outcomes.
Additionally, the bill increases nationwide efforts to monitor, research, and prevent the spread of infection from resistant organisms by
- establishing the Antimicrobial Resistance Surveillance and Laboratory Network in at least seven geographic regions,
- maintaining the Clinical Trials Network on Antimicrobial Resistance to conduct clinical research, and
- requiring collaboration with state and local agencies that support health care facilities that focus on preventing the spread of antibiotic-resistant bacteria.
